DNA damage resulted in the activation of the checkpoint kinases Chk1 and 2, subsequent tau phosphorylation at AD-related sites, and enhancement of tau-induced neurodegeneration in human tau expressing Drosophila (Iijima-Ando et al., 2010). The gene discussed is MAPT; the disease is Alzheimer disease.